Red Eye News and Research

RSS
Study provides genomic insights into life history tradeoffs in butterflies

Study provides genomic insights into life history tradeoffs in butterflies

Common sense concerns over Nerf gun eye injuries from doctors

Common sense concerns over Nerf gun eye injuries from doctors

Study opens the lid on overprescribing of antibiotics for acute conjunctivitis

Study opens the lid on overprescribing of antibiotics for acute conjunctivitis

Most people with acute conjunctivitis get wrong treatment, study suggests

Most people with acute conjunctivitis get wrong treatment, study suggests

First case of Zika virus found in Ohio

First case of Zika virus found in Ohio

FDA, EMA accept filing applications for Boehringer Ingelheim's afatinib to treat patients with advanced SCC of the lung

FDA, EMA accept filing applications for Boehringer Ingelheim's afatinib to treat patients with advanced SCC of the lung

Significant divide can exist between patients and physicians about same medical terms

Significant divide can exist between patients and physicians about same medical terms

Boehringer announces LUX-Lung 8 data that compares efficacy of afatinib, erlotinib in patients with advanced SCC

Boehringer announces LUX-Lung 8 data that compares efficacy of afatinib, erlotinib in patients with advanced SCC

OAO report calls for better care for people living with eye disease, vision problems in Ontario

OAO report calls for better care for people living with eye disease, vision problems in Ontario

CHLA infectious diseases specialist discusses how parents can prevent measles outbreak

CHLA infectious diseases specialist discusses how parents can prevent measles outbreak

Laundry detergent pods are dangerous for young children

Laundry detergent pods are dangerous for young children

New data on Gilotrif and investigational compounds to be presented at 50th ASCO annual meeting

New data on Gilotrif and investigational compounds to be presented at 50th ASCO annual meeting

NovaBay completes enrollment of patients in global Phase 2b viral conjunctivitis trial

NovaBay completes enrollment of patients in global Phase 2b viral conjunctivitis trial

Amakem commences Phase 2 dose-ranging study of AMA0076 drug for treatment of glaucoma

Amakem commences Phase 2 dose-ranging study of AMA0076 drug for treatment of glaucoma

Viral conjunctivitis: potential new treatment

Viral conjunctivitis: potential new treatment

Amakem commences AMA0076 Phase 2a study in glaucoma and ocular hypertension

Amakem commences AMA0076 Phase 2a study in glaucoma and ocular hypertension

Positive results from Bausch + Lomb, NicOx BOL‑303259‑X phase 2b study on OAG

Positive results from Bausch + Lomb, NicOx BOL‑303259‑X phase 2b study on OAG

Amakem receives €18m in Series A round of funding

Amakem receives €18m in Series A round of funding

VISINE launches new Maximum Redness Relief Formula

VISINE launches new Maximum Redness Relief Formula

GE Healthcare introduces new CESM technology to aid in breast cancer diagnosis

GE Healthcare introduces new CESM technology to aid in breast cancer diagnosis